Company Description
Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide.
It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers.
The company’s hemodialysis concentrate products are used to sustain patient’s life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream.
In addition, it offers dialysis concentrates, dialysis kits, and other ancillary products used in the dialysis process.
The company was formerly known as Rockwell Medical Technologies, Inc. and changed its name to Rockwell Medical, Inc. in June 2012.
Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.
| Country | United States |
| Founded | 1994 |
| IPO Date | Jan 27, 1998 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 157 |
| CEO | Mark Strobeck |
Contact Details
Address: 30142 South Wixom road Wixom, Michigan 48393 United States | |
| Phone | 248 960 9009 |
| Website | rockwellmed.com |
Stock Details
| Ticker Symbol | RMTI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001041024 |
| CUSIP Number | 774374300 |
| ISIN Number | US7743743004 |
| Employer ID | 38-3317208 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Mark Strobeck Ph.D. | President, Chief Executive Officer and Director |
| Jesse Neri | Senior Vice President and Chief Financial Officer |
| Megan C. Timmins | Executive Vice President, Chief Legal Officer and Secretary |
| Heather H. Hunter | Senior Vice President and Chief Operating Officer |
| Nicholas Fanslau | Controller and Principal Accounting Officer |
| Timothy T. Chole | Senior Vice President and Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 20, 2026 | PRE 14A | Other preliminary proxy statements |
| Mar 26, 2026 | 8-K | Current Report |
| Mar 26, 2026 | 10-K | Annual Report |
| Mar 26, 2026 | 8-K | Current Report |
| Jan 20, 2026 | 8-K | Current Report |
| Jan 5, 2026 | 144 | Filing |
| Jan 5, 2026 | 8-K | Current Report |
| Jan 2, 2026 | 144 | Filing |
| Nov 18, 2025 | 144 | Filing |
| Nov 18, 2025 | 8-K | Current Report |